Form 4: Stryker Corp Executive Glenn S. Boehnlein Exercises Stock Options and Sells Shares

Stryker's VP and Chief Financial Officer, Glenn S. Boehnlein, exercised stock options and sold shares on December 27, 2024.

Summary

• Glenn S. Boehnlein, VP and Chief Financial Officer of Stryker Corp, executed transactions involving company stock on December 27, 2024.
• He exercised 2,000 employee stock options at a price of $122.51 per share.
• Following the exercise, he sold 1,342 shares at $369.42 per share.
• After these transactions, Mr. Boehnlein directly owns 5,031 shares of Stryker stock.
• He also indirectly owns 1,554 shares through a 401K.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative in itself. It's a neutral event.

Industry Context

This filing is a routine disclosure of insider transactions and is common for executives who hold stock options as part of their compensation. It does not indicate any specific trend or event within the medical device industry.

Comparison to Industry Standards

• Executive stock option exercises and sales are a standard practice across publicly traded companies, including Stryker's competitors such as Medtronic, Johnson & Johnson, and Boston Scientific.
• The vesting schedule of 20% per year over five years is a common structure for long-term incentive plans.
• The reported transactions are consistent with typical executive compensation practices in the medical device sector.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are part of routine executive compensation and do not indicate any change in the company's fundamentals.

Key Dates

Keywords

Stryker, Stock Options, Insider Trading, SEC Form 4, Glenn S. Boehnlein, Executive Compensation, Share Transactions